Today: 7 February 2026
Subscribe
Browse Category

NYSE:SBSW News 27 December 2025 - 25 January 2026

Sibanye Stillwater Stock (NYSE: SBSW) Watch: Platinum’s Record Run Puts PGM Miner in the Spotlight Heading Into Monday

Sibanye Stillwater Stock (NYSE: SBSW) Watch: Platinum’s Record Run Puts PGM Miner in the Spotlight Heading Into Monday

Sibanye Stillwater’s U.S. shares closed at $15.70 Friday, up 3.97%, just below a 12-month high, as platinum surged to record levels above $2,400 an ounce. The company’s market cap stands at $11.28 billion, with a forward P/E near 5.5. Precious metals rallied sharply on supply concerns and European policy shifts, fueling volatility ahead of Monday’s market open.
28 December 2025
··
Sibanye Stillwater Limited Stock (SBSW) Watch: Platinum’s Record Run, Section 45X Tailwinds, and What to Know Before the Next NYSE Session

Sibanye Stillwater Limited Stock (SBSW) Watch: Platinum’s Record Run, Section 45X Tailwinds, and What to Know Before the Next NYSE Session

Sibanye Stillwater’s NYSE ADR closed at $15.70, up 3.9%, before U.S. equity markets shut for the weekend at 5:06 a.m. ET Saturday. The move follows platinum hitting a record $2,413.62/oz on December 26, driven by tight supply and an EU policy shift. Gold also reached an all-time high of $4,441.92/oz this week. SBSW trades near its 52-week peak.
27 December 2025
··

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
COPENHAGEN, February 7, 2026, 23:19 CET — Market closed. Novo Nordisk A/S Class B shares will be back in focus when trading resumes on Monday after telehealth firm Hims & Hers said it would stop offering access to a $49 compounded version of Novo’s Wegovy pill following U.S. regulatory warnings. Novo’s Copenhagen-listed shares ended Friday at 295.50 crowns, up 5.3%, according to Reuters market data. (Reuters) Why it matters now: the $49 offer put a fresh spotlight on how quickly cheaper, unapproved copies can spread in the fast-growing obesity-drug market — and how hard it may be for drugmakers to
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop